Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CGI | GIB | Nov 19, 2024 | 109.67 | +0.09 |
Chain Bridge Bancorp | CBNA | Nov 19, 2024 | 24.20 | 0.00 |
Chain Bridge I SPAC A | CBRG | Nov 19, 2024 | 11.49 | 0.00 |
Chain Bridge I Units | CBRGU | Nov 19, 2024 | 11.26 | 0.00 |
Champion Homes | SKY | Nov 19, 2024 | 98.75 | +2.03 |
Champions Oncology | CSBR | Nov 19, 2024 | 4.55 | +0.66 |
ChampionX | CHX | Nov 19, 2024 | 30.53 | -1.10 |
Chanson International | CHSN | Nov 19, 2024 | 8.10 | +25.78 |
ChargePoint | CHPT | Nov 19, 2024 | 1.13 | +0.89 |
Charles & Colvard | CTHR | Nov 19, 2024 | 1.31 | +1.55 |
Charles River Laboratories International | CRL | Nov 19, 2024 | 186.10 | -0.75 |
Charles Schwab | SCHW | Nov 19, 2024 | 80.19 | -1.47 |
Charlton Aria Acquisition Unit | CHARU | Nov 19, 2024 | 9.99 | 0.00 |
Chart Industries | GTLS-B | Nov 19, 2024 | 64.16 | +0.47 |
Chart Industries | GTLS | Nov 19, 2024 | 169.07 | +1.69 |
Charter Communications A | CHTR | Nov 19, 2024 | 384.84 | -0.05 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Nov 19, 2024 | 23.53 | -0.51 |
Chatham Lodging Trust REIT | CLDT | Nov 19, 2024 | 8.70 | -0.46 |
Cheche Group | CCG | Nov 19, 2024 | 0.85 | -1.50 |
Check Point Software Technolgies | CHKP | Nov 19, 2024 | 174.56 | +0.59 |
Check-Cap | CHEK | Nov 19, 2024 | 0.76 | -4.98 |
Checkpoint Therapeutics | CKPT | Nov 19, 2024 | 3.38 | +2.42 |
Cheer Holding | CHR | Nov 19, 2024 | 2.62 | -1.13 |
Cheetah Mobile ADR | CMCM | Nov 19, 2024 | 4.30 | +1.50 |
Cheetah Net Supply Chain Service | CTNT | Nov 19, 2024 | 1.94 | -2.02 |
Chegg | CHGG | Nov 19, 2024 | 1.68 | -2.89 |
Chemed | CHE | Nov 19, 2024 | 547.34 | -1.36 |
Chemomab Therapeutics ADR | CMMB | Nov 19, 2024 | 1.62 | -1.82 |
Chemours | CC | Nov 19, 2024 | 18.85 | -1.05 |
Chemung Financial | CHMG | Nov 19, 2024 | 50.65 | -1.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.